Leading Companies - Cancer Biologics Industry

Jun, 2023 - by CMI

Leading Companies - Cancer Biologics Industry

As more biologic drugs are approved by regulatory bodies for the treatment of cancer, the global market for cancer biologics is anticipated to develop significantly over the course of the projected period. For instance, in 2018, the U.S. Food and Drug Administration (FDA) approved the drug blinatumomab for patients with acute lymphoblastic leukemia of the B-cell precursor, which showed a decrease in the severity of the illness as the minimal residual disease (MRD) was found to be greater than or equal to 0.1%. For the treatment of metastatic advanced stage cutaneous squamous cell carcinoma, the US FDA also approved Cemiplimab-rwlc in 2018. 350 mg of cemiplimab-rwlc, administered as an intravenous infusion over 30 minutes, should be given to the patient once every three weeks.   

However, high cost associated with cancer biologic drug is one of the major restraint that is expected to hamper the global cancer biologics market growth. For instance, cost of blinatumomab is US$ 17,800 per year. Furthermore, side effects associated with cancer biologic drug such as allergic reactions, injection site reactions, weakness, diarrhea, nausea, vomiting, and rash yet remains another factor hindering the global Cancer Biologics Market  growth.                                                                             

Top Companies in the Cancer Biologics Industry:

1. Merck & Co

Merck & Co was founded in 1999 and it’s Rahway, New Jersey, United States. The company operates in 66 countries. In 2020 Merck today announced the acquisition of AmpTec, a leading Hamburg, . Merck opened its M Lab™ Collaboration Center in Shanghai,

2. Novartis International AG,

Novartis International AG, founded in 1992, and its Headquarters located in  Poway, California, United States. The company operates in 140 nations.

3 F. Hoffmann-La Roche AG

F. Hoffmann-La Roche AG , was launch in 1896 and it’s headquarter located Basel, Switzerland.it operate over 50 country. In 2023 F. Hoffmann-La Roche is the leading patent filer in monoclonal antibody conjugates for cancer treatment.

4 Eli Lilly and Company

Eli Lilly and Company was launch in 1876 and it’s headquarter Indianapolis, Indiana, United States.it operate over 18 country.

5 Bristol-Myers Squibb Company,

Bristol-Myers Squibb Company was founded 1887 with its headquarters in New York, New York, United States. With businesses in over 40 countries. In 2021 Bristol-Myers acquires Mead Johnson, maker of Enfamil baby formulas and other nutritional products. Pharmaceuticals included early anti-cancer ..

6. Pfizer Inc.

Pfizer Inc. was launch in 1849. And its headquarter - New York, New York, United States. It operate over 40 country. In 2023 Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion;

7 Sanofi S.A.

Dassault Aviation founded in 1973 and it’s headquarter located Paris, France.It operate over 70 country.In2022 Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China.

Definition- Biologic drug is a product that contain components of living organisms such as animal, human, or produced from living organisms.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.